about
Toll-like receptors and their soluble forms differ in the knee and thumb basal osteoarthritic joints.Laser-ultrasonic delivery of agents into articular cartilage.Soluble biglycan: a potential mediator of cartilage degradation in osteoarthritisToll-like receptors in human chondrocytes and osteoarthritic cartilage.Chemical and physical properties of regenerative medicine materials controlling stem cell fate.Cell adhesion and osteogenic differentiation on three-dimensional pillar surfaces.Do changing toll-like receptor profiles in different layers and grades of osteoarthritis cartilage reflect disease severity?IL-17C and its receptor IL-17RA/IL-17RE identify human oral epithelial cell as an inflammatory cell in recurrent aphthous ulcer.Altered Expression of Toll-like Receptors in Human Oral Epithelium in Oral Lichenoid Reactions.Characterization of polydactyly chondrocytes and their use in cartilage engineeringOsteoarthritis as an autoinflammatory disease caused by chondrocyte-mediated inflammatory responsesRole of innate immune sensors, TLRs, and NALP3 in rheumatoid arthritis and osteoarthritisSortase A as a cross-linking enzyme in tissue engineeringCartilage-targeting dexamethasone prodrugs increase the efficacy of dexamethasoneFunctional analysis of synovial fluid from osteoarthritic knee and carpometacarpal joints unravels different molecular profilesOsteoarthritis and Toll-Like Receptors: When Innate Immunity Meets Chondrocyte ApoptosisLocalized delivery of compounds into articular cartilage by using high-intensity focused ultrasoundLumican is upregulated in osteoarthritis and contributes to TLR4-induced pro-inflammatory activation of cartilage degradation and macrophage polarization
P50
Q33697107-6EE3BEA7-AEEA-4A82-8024-60E3AFC211A5Q36411857-1325015A-79D2-4161-93ED-55D411E04CF2Q36477482-F00491B3-C1E3-47A0-94C5-F030BDA36BAEQ37365265-80FA48E0-40CD-4F4B-B8B3-FBB31F78148EQ37875072-E5EE8A7F-5EBB-4376-B522-B8604857BF98Q39280837-B6AA903F-4771-4356-9334-3C3643B73E8FQ43602912-3C7CA12B-966E-4034-AC08-673C9596FF59Q50335941-2CDFCEBA-1161-42A2-AE56-06C19A761A24Q50987209-20409D4E-EBB7-4367-91F5-CCF8208F6489Q64105751-8BD43C73-8270-4461-B220-40DA606206D0Q82750741-D5DD4F58-F04C-450A-AAE0-3A2DB88A4A72Q86880807-6ADA353C-ED3E-477C-A9E8-2F6203EB4CFAQ90100893-45390FF2-4555-4B61-9352-0FDF9C59D837Q90671804-CEFF95D2-8288-4EA8-8F3E-D5C66BA8BE59Q90807726-EA6B07B5-8E05-4828-82FE-0DE5490B8243Q90809030-AFF6188A-2B47-450C-ADC3-D6819A4E68D6Q91105789-D9A77704-7F86-4A14-BD73-0721D2EABCA2Q91246188-28D82E2E-DC91-494E-A698-7C5A46916038
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
G Barreto
@en
G Barreto
@nl
type
label
G Barreto
@en
G Barreto
@nl
prefLabel
G Barreto
@en
G Barreto
@nl
P31
P496
0000-0003-4444-9208